Abstract
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have